Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Parratt

Showing results (11-20 of 228) with videos related to

Pageof 23
Sort By:
Journal of Molecular and Cellular Cardiology|April 1, 1995
Possibilities for the pharmacological exploitation of ischaemic preconditioningJ R Parratt
British Journal of Pharmacology|May 1, 1974
The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranololJ R Parratt
Basic Research in Cardiology|September 1, 1981
The evidence for alpha-adrenoceptors in the coronary circulation and their possible relevance to the physiological regulation of myocardial blood flowJ R Parratt
Cardiovascular Drugs and Therapy|May 1, 1988
Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactionsJ R Parratt
Cardiovascular Research|April 1, 1993
The discovery of ischaemic preconditioningJ R Parratt
Lancet (London, England)|February 21, 1981
Oxyfedrine as an antianginal agentJ R Parratt
Heart (British Cardiac Society)|January 1, 1998
Delayed protection against ventricular arrhythmias by cardiac pacingJ R Parratt, A Vegh
British Journal of Pharmacology|August 1, 1980
A comparison of the cardiovascular effects of dobutamine and a new dopamine derivative (D4975) during shock induced by E. coli endotoxinD McCaig, J R Parratt
British Journal of Pharmacology|September 1, 1981
Suppression by orally-administered nifedipine, nisoldipine and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischaemiaO Fagbemi, J R Parratt
Trends in Pharmacological Sciences|October 1, 1995
Delayed protection of the heart against ischaemiaJ R Parratt, L Szekeres
Pageof 23

Showing results (11-20 of 228) with videos related to

Sort By:
Pageof 23
Journal of Molecular and Cellular Cardiology|April 1, 1995
Possibilities for the pharmacological exploitation of ischaemic preconditioningJ R Parratt
British Journal of Pharmacology|May 1, 1974
The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranololJ R Parratt
Basic Research in Cardiology|September 1, 1981
The evidence for alpha-adrenoceptors in the coronary circulation and their possible relevance to the physiological regulation of myocardial blood flowJ R Parratt
Cardiovascular Drugs and Therapy|May 1, 1988
Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactionsJ R Parratt
Cardiovascular Research|April 1, 1993
The discovery of ischaemic preconditioningJ R Parratt
Lancet (London, England)|February 21, 1981
Oxyfedrine as an antianginal agentJ R Parratt
Heart (British Cardiac Society)|January 1, 1998
Delayed protection against ventricular arrhythmias by cardiac pacingJ R Parratt, A Vegh
British Journal of Pharmacology|August 1, 1980
A comparison of the cardiovascular effects of dobutamine and a new dopamine derivative (D4975) during shock induced by E. coli endotoxinD McCaig, J R Parratt
British Journal of Pharmacology|September 1, 1981
Suppression by orally-administered nifedipine, nisoldipine and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischaemiaO Fagbemi, J R Parratt
Trends in Pharmacological Sciences|October 1, 1995
Delayed protection of the heart against ischaemiaJ R Parratt, L Szekeres
Pageof 23